Mesothelin promotes brain metastasis of non-small cell lung cancer by activating MET
Brain metastasis (BM) is common among cases of advanced non-small cell lung cancer (NSCLC) and is the leading cause of death for these patients. Mesothelin (MSLN), a tumor-associated antigen expressed in many ...
Source: Journal of Experimental and Clinical Cancer Research - Category: Cancer & Oncology Authors: Shengkai Xia, Wenzhe Duan, Mingxin Xu, Mengqi Li, Mengyi Tang, Song Wei, Manqing Lin, Encheng Li, Wenwen Liu and Qi Wang Tags: Research Source Type: research
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | Lung Cancer | Men | Neurology | Non-Small Cell Lung Cancer